1. Home
  2. MXCT vs FRD Comparison

MXCT vs FRD Comparison

Compare MXCT & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.18

Market Cap

129.6M

Sector

Health Care

ML Signal

HOLD

Logo Friedman Industries Inc.

FRD

Friedman Industries Inc.

HOLD

Current Price

$23.54

Market Cap

134.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
FRD
Founded
1999
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
129.6M
134.3M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
MXCT
FRD
Price
$1.18
$23.54
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$5.50
N/A
AVG Volume (30 Days)
1.3M
25.9K
Earning Date
05-12-2026
06-11-2026
Dividend Yield
N/A
0.79%
EPS Growth
N/A
N/A
EPS
N/A
1.46
Revenue
$33,026,000.00
$121,157,278.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.50
N/A
P/E Ratio
N/A
$16.36
Revenue Growth
N/A
55.82
52 Week Low
$0.64
$14.52
52 Week High
$2.38
$24.69

Technical Indicators

Market Signals
Indicator
MXCT
FRD
Relative Strength Index (RSI) 64.09 66.39
Support Level $0.77 $18.15
Resistance Level $1.82 $24.37
Average True Range (ATR) 0.09 0.96
MACD 0.01 0.20
Stochastic Oscillator 60.00 75.74

Price Performance

Historical Comparison
MXCT
FRD

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About FRD Friedman Industries Inc.

Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.

Share on Social Networks: